Transradial versus transfemoral percutaneous coronary intervention in acute myocardial infarction. Systematic overview and meta-analysis

András Vorobcsuk, Attila Kónyi, D. Aradi, I. Horváth, Imre Ungi, Yves Louvard, A. Komócsi

Research output: Contribution to journalArticle

145 Citations (Scopus)

Abstract

Background: Although transradial percutaneous coronary intervention (TRPCI) is widely applied for percutaneous procedures, its safety in the setting of ST-segment elevation (STEMI) is controversial. Our aim was to assess the safety and efficacy of TRPCI versus transfemoral PCI in the context of treating patients suffering acute myocardial infarction with STEMI. Methods: Randomized, case-control, and cohort studies comparing access-related complications were analyzed. Our objective was to determine if radial access reduces major bleeding and thereby reduces death and ischemic events compared to femoral access in this setting. A fixed-effects model was used with random effects for sensitivity analysis. Results: Twelve studies involving 3324 patients were identified. Transradial PCI reduced major bleeding compared to transfemoral PCI (P = .0001), and significant reductions were found in the composite of death, myocardial infarction, or stroke (P = .001). Mortality reduction showed a significant toward benefit in the case of TRPCI (2.04% vs 3.06%, OR 0.54 [95% CI 0.33-0.86], P = .01). The fluoroscopic time was longer, and access site crossover was more frequent for TRPCI (P = .001, P <.00001, respectively). Conclusions: Transradial PCI reduces the risk of periprocedural major bleeding and major adverse events in the STEMI setting.

Original languageEnglish
Pages (from-to)814-821
Number of pages8
JournalAmerican Heart Journal
Volume158
Issue number5
DOIs
Publication statusPublished - Nov 2009

Fingerprint

Percutaneous Coronary Intervention
Meta-Analysis
Myocardial Infarction
Hemorrhage
Safety
Thigh
Case-Control Studies
Cohort Studies
Stroke
Mortality
ST Elevation Myocardial Infarction

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Transradial versus transfemoral percutaneous coronary intervention in acute myocardial infarction. Systematic overview and meta-analysis. / Vorobcsuk, András; Kónyi, Attila; Aradi, D.; Horváth, I.; Ungi, Imre; Louvard, Yves; Komócsi, A.

In: American Heart Journal, Vol. 158, No. 5, 11.2009, p. 814-821.

Research output: Contribution to journalArticle

@article{439bfe5ef264464e887005e7b3fef7d5,
title = "Transradial versus transfemoral percutaneous coronary intervention in acute myocardial infarction. Systematic overview and meta-analysis",
abstract = "Background: Although transradial percutaneous coronary intervention (TRPCI) is widely applied for percutaneous procedures, its safety in the setting of ST-segment elevation (STEMI) is controversial. Our aim was to assess the safety and efficacy of TRPCI versus transfemoral PCI in the context of treating patients suffering acute myocardial infarction with STEMI. Methods: Randomized, case-control, and cohort studies comparing access-related complications were analyzed. Our objective was to determine if radial access reduces major bleeding and thereby reduces death and ischemic events compared to femoral access in this setting. A fixed-effects model was used with random effects for sensitivity analysis. Results: Twelve studies involving 3324 patients were identified. Transradial PCI reduced major bleeding compared to transfemoral PCI (P = .0001), and significant reductions were found in the composite of death, myocardial infarction, or stroke (P = .001). Mortality reduction showed a significant toward benefit in the case of TRPCI (2.04{\%} vs 3.06{\%}, OR 0.54 [95{\%} CI 0.33-0.86], P = .01). The fluoroscopic time was longer, and access site crossover was more frequent for TRPCI (P = .001, P <.00001, respectively). Conclusions: Transradial PCI reduces the risk of periprocedural major bleeding and major adverse events in the STEMI setting.",
author = "Andr{\'a}s Vorobcsuk and Attila K{\'o}nyi and D. Aradi and I. Horv{\'a}th and Imre Ungi and Yves Louvard and A. Kom{\'o}csi",
year = "2009",
month = "11",
doi = "10.1016/j.ahj.2009.08.022",
language = "English",
volume = "158",
pages = "814--821",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",
number = "5",

}

TY - JOUR

T1 - Transradial versus transfemoral percutaneous coronary intervention in acute myocardial infarction. Systematic overview and meta-analysis

AU - Vorobcsuk, András

AU - Kónyi, Attila

AU - Aradi, D.

AU - Horváth, I.

AU - Ungi, Imre

AU - Louvard, Yves

AU - Komócsi, A.

PY - 2009/11

Y1 - 2009/11

N2 - Background: Although transradial percutaneous coronary intervention (TRPCI) is widely applied for percutaneous procedures, its safety in the setting of ST-segment elevation (STEMI) is controversial. Our aim was to assess the safety and efficacy of TRPCI versus transfemoral PCI in the context of treating patients suffering acute myocardial infarction with STEMI. Methods: Randomized, case-control, and cohort studies comparing access-related complications were analyzed. Our objective was to determine if radial access reduces major bleeding and thereby reduces death and ischemic events compared to femoral access in this setting. A fixed-effects model was used with random effects for sensitivity analysis. Results: Twelve studies involving 3324 patients were identified. Transradial PCI reduced major bleeding compared to transfemoral PCI (P = .0001), and significant reductions were found in the composite of death, myocardial infarction, or stroke (P = .001). Mortality reduction showed a significant toward benefit in the case of TRPCI (2.04% vs 3.06%, OR 0.54 [95% CI 0.33-0.86], P = .01). The fluoroscopic time was longer, and access site crossover was more frequent for TRPCI (P = .001, P <.00001, respectively). Conclusions: Transradial PCI reduces the risk of periprocedural major bleeding and major adverse events in the STEMI setting.

AB - Background: Although transradial percutaneous coronary intervention (TRPCI) is widely applied for percutaneous procedures, its safety in the setting of ST-segment elevation (STEMI) is controversial. Our aim was to assess the safety and efficacy of TRPCI versus transfemoral PCI in the context of treating patients suffering acute myocardial infarction with STEMI. Methods: Randomized, case-control, and cohort studies comparing access-related complications were analyzed. Our objective was to determine if radial access reduces major bleeding and thereby reduces death and ischemic events compared to femoral access in this setting. A fixed-effects model was used with random effects for sensitivity analysis. Results: Twelve studies involving 3324 patients were identified. Transradial PCI reduced major bleeding compared to transfemoral PCI (P = .0001), and significant reductions were found in the composite of death, myocardial infarction, or stroke (P = .001). Mortality reduction showed a significant toward benefit in the case of TRPCI (2.04% vs 3.06%, OR 0.54 [95% CI 0.33-0.86], P = .01). The fluoroscopic time was longer, and access site crossover was more frequent for TRPCI (P = .001, P <.00001, respectively). Conclusions: Transradial PCI reduces the risk of periprocedural major bleeding and major adverse events in the STEMI setting.

UR - http://www.scopus.com/inward/record.url?scp=70350048414&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350048414&partnerID=8YFLogxK

U2 - 10.1016/j.ahj.2009.08.022

DO - 10.1016/j.ahj.2009.08.022

M3 - Article

C2 - 19853703

AN - SCOPUS:70350048414

VL - 158

SP - 814

EP - 821

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 5

ER -